Drug profile · INN
polymyxin b sulfate
AEROSPORIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
polymyxin b sulfate (AEROSPORIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN polymyxin b sulfate
Brand AEROSPORIN
Route OPHTHALMIC
Formulation INJECTABLE
Frequently asked questions
What is polymyxin b sulfate?
polymyxin b sulfate (AEROSPORIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for polymyxin b sulfate?
AEROSPORIN is a marketed brand name for polymyxin b sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of polymyxin b sulfate?
polymyxin b sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.